Sanuj K. Ravindran

2016

In 2016, Sanuj K. Ravindran earned a total compensation of $1.7M as Chief Business Officer at aTYR PHARMA.

Compensation breakdown

Bonus$25,000
Non-Equity Incentive Plan$75,000
Option Awards$1,096,130
Salary$373,798
Other$91,422
Total$1,661,350

Ravindran received $1.1M in option awards, accounting for 66% of the total pay in 2016.

Ravindran also received $25K in bonus, $75K in non-equity incentive plan, $373.8K in salary and $91.4K in other compensation.

Rankings

In 2016, Sanuj K. Ravindran's compensation ranked 5,762nd out of 14,075 executives tracked by ExecPay. In other words, Ravindran earned more than 59.1% of executives.

ClassificationRankingPercentile
All
5,762
out of 14,075
59th
Division
Manufacturing
2,088
out of 5,489
62nd
Major group
Chemicals And Allied Products
677
out of 1,895
64th
Industry group
Drugs
506
out of 1,538
67th
Industry
Biological Products, Except Diagnostic Substances
89
out of 279
68th
Source: SEC filing on March 30, 2017.

Ravindran's colleagues

We found two more compensation records of executives who worked with Sanuj K. Ravindran at aTYR PHARMA in 2016.

2016

John Mendlein

aTYR PHARMA

Chief Executive Officer

2016

Sanjay Shukla

aTYR PHARMA

Chief Medical Officer

In-depth

You may also like